FINWIRES · TerminalLIVE
FINWIRES

Transat社、モントリオール発2026-27年冬季便にアルバ、バルバドス、カボを追加

By

-- Transat A.T(TRZ.TO)は月曜日、2026~2027年冬期スケジュールにモントリオール発着の新たな3つのリゾート地を追加すると発表した。 新路線は、アルバのオラニエスタッド、バルバドスのブリッジタウン、メキシコのサンホセ・デル・カボ。サンホセ・デル・カボ行きは12月10日から週1便、オラニエスタッド行きは12月12日から週1便、ブリッジタウン行きは12月13日から週2便となる。 「リゾート地への需要は依然として高く、モントリオール発着のこれら3つの新路線は、当社のサービスを拡大することで、その需要に応えるものです。アルバ、バルバドス、ロス・カボスへの路線を追加することで、お客様の利益のために、南米方面へのネットワークの多様化と最適化に重点を置いた戦略を着実に実行していきます」と、最高収益責任者(CRO)のセバスチャン・ポンセ氏は述べた。 これらのフライトは現在予約受付中ですが、運航許可や空港の利用状況によってはスケジュールが変更される可能性があります。エア・トランザットは今後数週間で冬期運航プログラムの詳細を順次発表していく予定です。 トランザットの株価はトロント証券取引所で0.02ドル高の2.63ドルで取引を終えました。

Price: $2.60, Change: $-0.01, Percent Change: -0.38%

Related Articles

Asia

Ora Banda Mining Appoints Chair-elect

Ora Banda Mining (ASX:OBM) has appointed John Richards as chair-elect, with plans for him to assume the role following the retirement of current Chair Peter Mansell at the company's annual general meeting in November, according to a Tuesday filing with the Australian bourse.Richards is currently non-executive chair of Sandfire Resources (ASX:SFR) and lead independent non-executive director of Sheffield Resources (ASX:SFX), the filing added.

$ASX:OBM$ASX:SFR$ASX:SFX
Research

Research Alert: Universal Health Services: Q1 Eps Tops Estimates

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:UHS delivered solid Q1 results, with adjusted EPS of $5.62 (up 16.1% Y/Y), $0.16 above consensus, while revenue grew 9.6% to $4.495B due to higher prices despite modest patient volumes. Same-facility acute care revenue increased 8.2% on flat adjusted admissions but 6.3% growth in revenue per admission, while behavioral health saw 1.2% admission growth and 7.3% revenue growth. We think the $835M Talkspace acquisition may expand UHS's virtual behavioral health capabilities and broaden payor mix. Management expects the deal to close in Q3. Operating cash flow improved 11.7% to $402M, and UHS repurchased $127.3M in stock, though adjusted EBITDA margin compressed 20 bps to 14.4% on higher operating expenses. We think behavioral health staffing challenges persist but expect the Talkspace integration to create growth opportunities.

$UHS
Research

Research Alert: Cls Q1: Blistering Fy 26 Guidance And Cpo Win Tempered By Capital Demands

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Q1 revenues of $4.05B (+53%) and adjusted EPS of $2.16 (+80%) both exceeded guidance on accelerating hyperscaler demand. Adjusted operating margin reached a record 8.0%, due to higher-value CCS offerings, which grew 76% to $3.24B, with segment margin expanding to 8.6%. The company secured a new CPO switch program with a hyperscaler customer expected to ramp in 2027, and we expect more color tomorrow. Management raised 2026 guidance to $19.0B revenue (from $17.0B) and $10.15 adjusted EPS (from $8.75), representing over $6.5B in revenue growth. Stronger growth is anticipated for 2027 based on improved customer visibility and new program wins. The company enlarged its balance sheet by upsizing its credit facility to $2.5B, with revolver capacity increased to $1.75B. FCF of $137.9M remained robust despite elevated capex of $218.4M to support capacity expansion. Share buybacks slowing, FCF guidance lagging, and a +50% month may be contributing to the after-hours selloff.

$CLS